MaxLinear, Inc. Announces Third Quarter 2021 Financial Results
MaxLinear, a leader in integrated circuits, reported record net revenue of $229.8 million for Q3 2021, a 12% sequential increase and 47% year-over-year growth. The GAAP gross margin improved to 56.5%, from 54.8% in Q2 2021, while non-GAAP gross margin reached 61.3%. Operating expenses decreased to $106.0 million, or 46% of net revenue. The company expects Q4 revenue between $240 million and $250 million, with GAAP gross margin estimates between 55.5% and 57.5%.
- Record revenue of $229.8 million, up 47% year-over-year.
- GAAP gross margin increased to 56.5%, up from 54.8% in the prior quarter.
- Non-GAAP gross margin rose to 61.3%, exceeding previous expectations.
- Operating expenses decreased to $106.0 million, improving efficiency.
- GAAP operating expenses still constitute 46% of revenue, indicating a need for further cost control.
-
Record net revenue of
, up$229.8 million 12% sequentially and up47% year-over-year -
GAAP gross margin
56.5% and non-GAAP gross margin61.3% , up 170 bps and 110 bps from previous quarter, respectively
Third Quarter Financial Highlights
GAAP basis:
-
Net revenue was
, up$229.8 million 12% sequentially and up47% year-over-year. -
GAAP gross margin was
56.5% , compared to54.8% in the prior quarter, and42.3% in the year-ago quarter. -
GAAP operating expenses were
in the third quarter 2021, or$106.0 million 46% of net revenue, compared to in the prior quarter, or$110.3 million 54% of net revenue, and in the year-ago quarter, or$100.8 million 64% of net revenue. -
GAAP income from operations was
10% of revenue, compared to income from operations of1% in the prior quarter, and loss from operations of22% in the year-ago quarter. -
Net cash flow provided by operating activities was
, compared to net cash flow provided by operating activities of$84.1 million in the prior quarter, and net cash flow used in operating activities of$7.9 million in the year-ago quarter.$16.6 million -
GAAP diluted earnings per share was
, compared to diluted earnings per share of$0.12 in the prior quarter, and diluted loss per share of$0.01 in the year-ago quarter.$0.50
Non-GAAP basis:
-
Non-GAAP gross margin was
61.3% . This compares to60.2% in the prior quarter, and58.0% in the year-ago quarter. -
Non-GAAP operating expenses were
, or$74.4 million 32% of revenue, compared to or$75.2 million 37% of revenue in the prior quarter, and or$61.1 million 39% of revenue in the year-ago quarter. -
Non-GAAP income from operations was
29% of revenue, compared to24% in the prior quarter, and19% in the year-ago quarter. -
Non-GAAP diluted earnings per share was
, compared to diluted earnings per share of$0.75 in the prior quarter, and diluted earnings per share of$0.53 in the year-ago quarter.$0.32
Management Commentary
“In the third quarter, revenue was up
Fourth Quarter 2021 Business Outlook
The company expects revenue in the fourth quarter 2021 to be approximately
-
GAAP gross margin of approximately
55.5% to57.5% ; -
Non-GAAP gross margin of approximately
60.0% to62.0% ; -
GAAP operating expenses of approximately
to$105.0 million ;$109.0 million -
Non-GAAP operating expenses of approximately
to$73.0 million ;$77.0 million -
GAAP interest and other expense of approximately
to$2.7 million ; and$2.8 million -
Non-GAAP interest and other expense of approximately
to$2.6 million .$2.7 million
Webcast and Conference Call
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others, statements concerning our future financial performance (including specifically our current guidance for fourth quarter 2021 revenue, gross margins, and operating expenses as well as statements with respect to confidence in the Company’s outlook for the balance of 2021 and into 2022) and statements concerning expectations of potential developments in our target markets, including (without limitation) management’s views with respect to the prospects for and trends in our broadband, connectivity and 5G wireless and fiber-optic high-speed interconnect infrastructure markets. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to be materially different from any future results expressed or implied by the forward-looking statements. Forward-looking statements are based on management’s current, preliminary expectations and are subject to various risks and uncertainties. In particular, our future operating results are substantially dependent on our assumptions about market trends and conditions. Additional risks and uncertainties affecting our business and future operating results include, without limitation, increasing supply chain risks within our industry, including increases in shipping and material costs and substantial shipping delays resulting in extended lead-times; inflation trends in our supply chain and in the global economy generally; the on-going impact of the COVID-19 pandemic on our business, including the extent to which our broadband businesses will continue to benefit from work-from-home and similar initiatives as the pandemic abates; the impact of our indebtedness and limitations on our operating flexibility based on financial and operating covenants in the applicable term loan agreements, including (without limitation) debt covenant restrictions that may limit our ability to obtain additional financing, granting liens, undergoing certain fundamental changes, or making investments or certain restricted payments, and selling assets; risks associated with our ability to realize improved profitability from our Wi-Fi and Broadband assets business; intense competition in our industry; our dependence on a limited number of customers for a substantial portion of our revenues; potential uncertainties arising from continued consolidation among cable television and satellite operators in our target markets and continued consolidation among competitors within the semiconductor industry generally; our ability to develop and introduce new and enhanced products on a timely basis and achieve market acceptance of those products, particularly as we seek to expand outside of our historic markets; potential decreases in average selling prices for our products; risks relating to intellectual property protection and the prevalence of intellectual property litigation in our industry; our reliance on a limited number of third party manufacturers; our lack of long-term supply contracts and dependence on limited sources of supply, which may be adversely affected by the pandemic; uncertainties concerning how end user markets for our products will develop, including in particular markets we have entered more recently such as broadband and Wi-Fi and 5G wireless and fiber-optic data center high-speed interconnect infrastructure markets but also existing markets which we previously referred to as connected home; and uncertainties concerning the outcome of global trade negotiations, export control limitations, and heightened geopolitical risks generally.
In addition to these risks and uncertainties, investors should review the risks and uncertainties contained in our filings with the
Use of Non-GAAP Financial Measures
To supplement our unaudited consolidated financial statements presented on a basis consistent with GAAP, we disclose certain non-GAAP financial measures, including non-GAAP gross margin, operating expenses, operating expenses as a percentage of revenue, income from operations as percentage of revenue, and diluted earnings per share. These supplemental measures exclude the effects of (i) stock-based compensation expense; (ii) accruals related to our performance based bonus plan for 2021, which we currently intend to settle in shares of our common stock; (iii) accruals related to our performance based bonus plan for 2020, which we settled in shares of common stock in 2021; (iv) amortization of inventory fair value adjustments; (v) amortization of purchased intangible assets; (vi) research and development funded by others; (vii) acquisition and integration costs related to our acquisitions; (viii) professional fees and settlement costs related to IP and commercial litigation matters; (ix) severance and other restructuring charges; (x) impairment losses on intangible assets; (xi) loss from extinguishment of debt; (xii) other non-recurring interest and other income (expenses), net attributable to acquisitions and (xiii) non-cash income tax benefits and expenses. These non-GAAP measures are not in accordance with and do not serve as an alternative for GAAP. We believe that these non-GAAP measures have limitations in that they do not reflect all of the amounts associated with our GAAP results of operations. These non-GAAP measures should only be viewed in conjunction with corresponding GAAP measures. We compensate for the limitations of non-GAAP financial measures by relying upon GAAP results to gain a complete picture of our performance.
We believe that non-GAAP financial measures can provide useful information to both management and investors by excluding certain non-cash and other one-time expenses that are not indicative of our core operating results. Among other uses, our management uses non-GAAP measures to compare our performance relative to forecasts and strategic plans and to benchmark our performance externally against competitors. In addition, management’s incentive compensation will be determined in part using these non-GAAP measures because we believe non-GAAP measures better reflect our core operating performance.
The following are explanations of each type of adjustment that we incorporate into non-GAAP financial measures:
Stock-based compensation expense relates to equity incentive awards granted to our employees, directors, and consultants. Our equity incentive plans are important components of our employee incentive compensation arrangements and are reflected as expenses in our GAAP results. Stock-based compensation expense has been and will continue to be a significant recurring expense for
Bonuses under our executive and non-executive bonus programs have been excluded from our non-GAAP net income for all periods reported. Bonus payments for the 2020 performance periods were settled through the issuance of shares of common stock under our equity incentive plans in
Expenses incurred in relation to acquisitions include amortization of purchased intangible assets, amortization of inventory fair value adjustments, acquisition and integration costs primarily consisting of professional and consulting fees, and amortization of discount on deferred purchase price payments to interest expense.
Research and development funded by others represents proceeds received under a contract for a jointly funded R&D project to develop technology that may be commercialized into a product in the future. Such proceeds have not yet been recognized in GAAP results as the Company may be required to repay all or a portion of the funds provided by the other party under certain conditions. Management believes it is not probable that it will trigger such conditions.
Impairment losses relate to certain intangible assets.
Restructuring charges incurred are related to our restructuring plans which eliminate redundancies and primarily include severance and restructuring costs related to impairment of leased right-of-use assets or from exiting certain facilities.
Loss on extinguishment of debt is related to the charge-off of remaining unamortized debt discount and issuance costs on debt we repaid early with proceeds from a new term loan in
Expenses incurred in relation to our intellectual property and commercial litigation include professional fees incurred.
Income tax benefits and expense adjustments are those that do not affect cash income taxes payable.
Reconciliations of non-GAAP measures for the historic periods disclosed in this press release appear below. Because of the inherent uncertainty associated with our ability to project future charges, particularly related to stock-based compensation and its related tax effects as well as potential impairments, we have not provided a reconciliation for non-GAAP guidance provided for the fourth quarter 2021.
About
MXL is MaxLinear’s registered trademark. Other trademarks appearing herein are the property of their respective owners.
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data) |
||||||||||||
|
Three Months Ended |
|||||||||||
|
|
|
|
|
|
|||||||
Net revenue |
$ |
229,774 |
|
|
$ |
205,376 |
|
|
$ |
156,633 |
|
|
Cost of net revenue |
99,981 |
|
|
92,833 |
|
|
90,427 |
|
||||
Gross profit |
129,793 |
|
|
112,543 |
|
|
66,206 |
|
||||
Operating expenses: |
|
|
|
|
|
|||||||
Research and development |
67,538 |
|
|
74,416 |
|
|
55,816 |
|
||||
Selling, general and administrative |
38,469 |
|
|
35,885 |
|
|
41,685 |
|
||||
Restructuring charges |
— |
|
|
38 |
|
|
3,280 |
|
||||
Total operating expenses |
106,007 |
|
|
110,339 |
|
|
100,781 |
|
||||
Income (loss) from operations |
23,786 |
|
|
2,204 |
|
|
(34,575 |
) |
||||
Interest income |
28 |
|
|
18 |
|
|
27 |
|
||||
Interest expense |
(2,649 |
) |
|
(3,741 |
) |
|
(3,569 |
) |
||||
Loss on extinguishment of debt |
— |
|
|
(5,221 |
) |
|
— |
|
||||
Other income (expense), net |
(105 |
) |
|
(537 |
) |
|
(719 |
) |
||||
Total other income (expense), net |
(2,726 |
) |
|
(9,481 |
) |
|
(4,261 |
) |
||||
Income (loss) before income taxes |
21,060 |
|
|
(7,277 |
) |
|
(38,836 |
) |
||||
Income tax provision (benefit) |
11,802 |
|
|
(8,010 |
) |
|
(2,191 |
) |
||||
Net income (loss) |
$ |
9,258 |
|
|
$ |
733 |
|
|
$ |
(36,645 |
) |
|
Net income (loss) per share: |
|
|
|
|
|
|||||||
Basic |
$ |
0.12 |
|
|
$ |
0.01 |
|
|
$ |
(0.50 |
) |
|
Diluted |
$ |
0.12 |
|
|
$ |
0.01 |
|
|
$ |
(0.50 |
) |
|
Shares used to compute net income (loss) per share: |
|
|
|
|
|
|||||||
Basic |
76,582 |
|
|
75,930 |
|
|
73,402 |
|
||||
Diluted |
79,815 |
|
|
79,026 |
|
|
73,402 |
|
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data) |
||||||||
|
|
|
|
|||||
|
Nine months ended |
|||||||
|
|
|
|
|||||
Net revenue |
$ |
644,509 |
|
|
$ |
283,880 |
|
|
Cost of net revenue |
290,454 |
|
|
154,169 |
|
|||
Gross profit |
354,055 |
|
|
129,711 |
|
|||
Operating expenses: |
|
|
|
|||||
Research and development |
205,120 |
|
|
109,489 |
|
|||
Selling, general and administrative |
110,823 |
|
|
93,787 |
|
|||
Impairment losses |
— |
|
|
86 |
|
|||
Restructuring charges |
2,204 |
|
|
3,833 |
|
|||
Total operating expenses |
318,147 |
|
|
207,195 |
|
|||
Income (loss) from operations |
35,908 |
|
|
(77,484 |
) |
|||
Interest income |
46 |
|
|
283 |
|
|||
Interest expense |
(10,596 |
) |
|
(8,228 |
) |
|||
Loss on extinguishment of debt |
(5,221 |
) |
|
— |
|
|||
Other income (expense), net |
(746 |
) |
|
(620 |
) |
|||
Total other income (expense), net |
(16,517 |
) |
|
(8,565 |
) |
|||
Income (loss) before income taxes |
19,391 |
|
|
(86,049 |
) |
|||
Income tax provision (benefit) |
5,598 |
|
|
(12,128 |
) |
|||
Net income (loss) |
$ |
13,793 |
|
|
$ |
(73,921 |
) |
|
Net income (loss) per share: |
|
|
|
|||||
Basic |
$ |
0.18 |
|
|
$ |
(1.02 |
) |
|
Diluted |
$ |
0.17 |
|
|
$ |
(1.02 |
) |
|
Shares used to compute net income (loss) per share: |
|
|
|
|||||
Basic |
75,795 |
|
|
72,729 |
|
|||
Diluted |
79,048 |
|
|
72,729 |
|
|||
|
|
|
|
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) |
||||||||||||
|
Three Months Ended |
|||||||||||
|
|
|
|
|
|
|||||||
Operating Activities |
|
|
|
|
|
|||||||
Net income (loss) |
$ |
9,258 |
|
|
$ |
733 |
|
|
$ |
(36,645 |
) |
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |
|
|
|
|
|
|||||||
Amortization and depreciation |
23,117 |
|
|
21,997 |
|
|
20,554 |
|
||||
Amortization of inventory fair value adjustments |
— |
|
|
— |
|
|
14,445 |
|
||||
Amortization of debt issuance costs and accretion of discount on debt and leases |
513 |
|
|
918 |
|
|
579 |
|
||||
Stock-based compensation |
16,022 |
|
|
13,966 |
|
|
14,145 |
|
||||
Deferred income taxes |
6,866 |
|
|
(6,002 |
) |
|
3,834 |
|
||||
Loss on disposal of property and equipment |
145 |
|
|
20 |
|
|
— |
|
||||
Impairment of leasehold improvements |
— |
|
|
— |
|
|
156 |
|
||||
Impairment of leased right-of-use assets |
— |
|
|
— |
|
|
1,464 |
|
||||
Loss on extinguishment of debt |
— |
|
|
5,221 |
|
|
— |
|
||||
(Gain) loss on foreign currency and other |
(24 |
) |
|
387 |
|
|
601 |
|
||||
Excess tax benefits on stock based awards |
(738 |
) |
|
(2,822 |
) |
|
(152 |
) |
||||
Changes in operating assets and liabilities, net of effects of acquisitions: |
|
|
|
|
|
|||||||
Accounts receivable |
28,454 |
|
|
(47,800 |
) |
|
(63,569 |
) |
||||
Inventory |
(28,844 |
) |
|
(6,254 |
) |
|
(17,349 |
) |
||||
Prepaid expenses and other assets |
39 |
|
|
3,588 |
|
|
(35,131 |
) |
||||
Leased right-of-use assets |
— |
|
|
36 |
|
|
79 |
|
||||
Accounts payable, accrued expenses and other current liabilities |
28,743 |
|
|
8,652 |
|
|
61,958 |
|
||||
Accrued compensation |
8,616 |
|
|
13,857 |
|
|
15,364 |
|
||||
Accrued price protection liability |
(5,319 |
) |
|
(344 |
) |
|
12,108 |
|
||||
Lease liabilities |
(2,723 |
) |
|
(2,345 |
) |
|
(1,566 |
) |
||||
Other long-term liabilities |
(48 |
) |
|
4,043 |
|
|
(7,459 |
) |
||||
Net cash provided by (used in) operating activities |
84,077 |
|
|
7,851 |
|
|
(16,584 |
) |
||||
Investing Activities |
|
|
|
|
|
|||||||
Purchases of property and equipment |
(9,624 |
) |
|
(11,158 |
) |
|
(5,196 |
) |
||||
Purchases of intangible assets |
(5,504 |
) |
|
— |
|
|
(375 |
) |
||||
Cash used in acquisitions, net of cash acquired |
(7,500 |
) |
|
(7,500 |
) |
|
(160,000 |
) |
||||
Net cash used in investing activities |
(22,628 |
) |
|
(18,658 |
) |
|
(165,571 |
) |
||||
Financing Activities |
|
|
|
|
|
|||||||
Proceeds from the issuance of debt |
— |
|
|
350,000 |
|
|
— |
|
||||
Payment of debt issuance cost |
(17 |
) |
|
(4,127 |
) |
|
(2,696 |
) |
||||
Repayment of debt |
(20,000 |
) |
|
(349,813 |
) |
|
— |
|
||||
Net proceeds from issuance of common stock |
192 |
|
|
4,796 |
|
|
628 |
|
||||
Minimum tax withholding paid on behalf of employees for restricted stock units |
(976 |
) |
|
(2,663 |
) |
|
(1,393 |
) |
||||
Repurchase of common stock |
(1,008 |
) |
|
(4,464 |
) |
|
— |
|
||||
Net cash provided by (used in) financing activities |
(21,809 |
) |
|
(6,271 |
) |
|
171,539 |
|
||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
(520 |
) |
|
(681 |
) |
|
(71 |
) |
||||
Increase (decrease) in cash, cash equivalents and restricted cash |
39,120 |
|
|
(17,759 |
) |
|
(10,687 |
) |
||||
Cash, cash equivalents and restricted cash at beginning of period |
131,434 |
|
|
149,193 |
|
|
107,429 |
|
||||
Cash, cash equivalents and restricted cash at end of period |
$ |
170,554 |
|
|
$ |
131,434 |
|
|
$ |
96,742 |
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) |
||||||||
|
Nine months ended |
|||||||
|
|
|
|
|||||
Operating Activities |
|
|
|
|||||
Net income (loss) |
$ |
13,793 |
|
|
$ |
(73,921 |
) |
|
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities: |
|
|
|
|||||
Amortization and depreciation |
67,439 |
|
|
53,819 |
|
|||
Impairment losses |
— |
|
|
86 |
|
|||
Amortization of inventory fair value adjustments |
— |
|
|
14,445 |
|
|||
Amortization of debt issuance costs and accretion of discount on debt and leases |
2,584 |
|
|
1,386 |
|
|||
Stock-based compensation |
42,943 |
|
|
33,057 |
|
|||
Deferred income taxes |
1,405 |
|
|
(5,253 |
) |
|||
Loss on disposal of property and equipment |
533 |
|
|
— |
|
|||
Impairment of leasehold improvements |
226 |
|
|
319 |
|
|||
Impairment of leased right-of-use assets |
429 |
|
|
1,508 |
|
|||
Loss on extinguishment of debt |
5,221 |
|
|
— |
|
|||
Loss on foreign currency |
384 |
|
|
375 |
|
|||
Excess tax benefits on stock-based awards |
(5,369 |
) |
|
(530 |
) |
|||
Changes in operating assets and liabilities, net of effects of acquisitions: |
|
|
|
|||||
Accounts receivable |
(39,425 |
) |
|
(54,592 |
) |
|||
Inventory |
(29,440 |
) |
|
(20,180 |
) |
|||
Prepaid expenses and other assets |
33,487 |
|
|
(34,357 |
) |
|||
Leased right-of-use assets |
72 |
|
|
405 |
|
|||
Accounts payable, accrued expenses and other current liabilities |
35,054 |
|
|
67,193 |
|
|||
Accrued compensation |
23,849 |
|
|
23,121 |
|
|||
Accrued price protection liability |
1,636 |
|
|
5,439 |
|
|||
Lease liabilities |
(7,070 |
) |
|
(4,275 |
) |
|||
Other long-term liabilities |
4,449 |
|
|
(8,721 |
) |
|||
Net cash provided by (used in) operating activities |
152,200 |
|
|
(676 |
) |
|||
Investing Activities |
|
|
|
|||||
Purchases of property and equipment |
(26,934 |
) |
|
(10,132 |
) |
|||
Purchases of intangible assets |
(6,616 |
) |
|
(388 |
) |
|||
Cash used in acquisitions, net of cash acquired |
(35,000 |
) |
|
(160,000 |
) |
|||
Purchases of available-for-sale securities |
(5,000 |
) |
|
— |
|
|||
Net cash used in investing activities |
(73,550 |
) |
|
(170,520 |
) |
|||
Financing Activities |
|
|
|
|||||
Proceeds from the issuance of debt |
350,000 |
|
|
175,000 |
|
|||
Payment of debt issuance cost |
(4,144 |
) |
|
(2,696 |
) |
|||
Repayment of debt |
(389,813 |
) |
|
— |
|
|||
Net proceeds from issuance of common stock |
6,286 |
|
|
5,270 |
|
|||
Minimum tax withholding paid on behalf of employees for restricted stock units |
(11,081 |
) |
|
(2,892 |
) |
|||
Repurchase of common stock |
(8,145 |
) |
|
— |
|
|||
Net cash provided by (used in) financing activities |
(56,897 |
) |
|
174,682 |
|
|||
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
(1,233 |
) |
|
139 |
|
|||
Increase in cash, cash equivalents and restricted cash |
20,520 |
|
|
3,625 |
|
|||
Cash, cash equivalents and restricted cash at beginning of period |
150,034 |
|
|
93,117 |
|
|||
Cash, cash equivalents and restricted cash at end of period |
$ |
170,554 |
|
|
$ |
96,742 |
|
UNAUDITED GAAP CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) |
|||||||||
|
|
|
|
|
|
||||
Assets |
|
|
|
|
|
||||
Current assets: |
|
|
|
|
|
||||
Cash and cash equivalents |
$ |
169,424 |
|
$ |
130,312 |
|
$ |
96,570 |
|
Short-term restricted cash |
107 |
|
107 |
|
111 |
||||
Accounts receivable, net |
106,867 |
|
135,321 |
|
105,355 |
||||
Inventory |
127,347 |
|
98,502 |
|
104,471 |
||||
Prepaid expenses and other current assets |
14,535 |
|
13,866 |
|
43,546 |
||||
Total current assets |
418,280 |
|
378,108 |
|
350,053 |
||||
Long-term restricted cash |
1,023 |
|
1,015 |
|
61 |
||||
Property and equipment, net |
53,022 |
|
48,104 |
|
37,258 |
||||
Leased right-of-use assets |
23,668 |
|
22,847 |
|
11,876 |
||||
Intangible assets, net |
163,894 |
|
174,964 |
|
232,148 |
||||
|
302,828 |
|
302,828 |
|
302,576 |
||||
Deferred tax assets |
84,660 |
|
91,526 |
|
72,537 |
||||
Other long-term assets |
6,519 |
|
7,235 |
|
1,270 |
||||
Total assets |
$ |
1,053,894 |
|
$ |
1,026,627 |
|
$ |
1,007,779 |
|
|
|
|
|
|
|
||||
Liabilities and stockholders’ equity |
|
|
|
|
|
||||
Current liabilities |
$ |
231,274 |
|
$ |
211,789 |
|
$ |
211,374 |
|
Long-term lease liabilities |
21,400 |
|
20,445 |
|
9,406 |
||||
Long-term debt |
326,027 |
|
343,022 |
|
372,457 |
||||
Other long-term liabilities |
17,650 |
|
17,704 |
|
17,734 |
||||
Stockholders’ equity |
457,543 |
|
433,667 |
|
396,808 |
||||
Total liabilities and stockholders’ equity |
$ |
1,053,894 |
|
$ |
1,026,627 |
|
$ |
1,007,779 |
UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENTS (in thousands, except per share data) |
||||||||||||
|
Three Months Ended |
|||||||||||
|
|
|
|
|
|
|||||||
GAAP gross profit |
$ |
129,793 |
|
|
$ |
112,543 |
|
|
$ |
66,206 |
|
|
Stock-based compensation |
151 |
|
|
148 |
|
|
143 |
|
||||
Performance based equity |
123 |
|
|
127 |
|
|
180 |
|
||||
Amortization of inventory fair value adjustments |
— |
|
|
— |
|
|
14,445 |
|
||||
Amortization of purchased intangible assets |
10,743 |
|
|
10,743 |
|
|
9,901 |
|
||||
Non-GAAP gross profit |
140,810 |
|
|
123,561 |
|
|
90,875 |
|
||||
|
|
|
|
|
|
|||||||
GAAP R&D expenses |
67,538 |
|
|
74,416 |
|
|
55,816 |
|
||||
Stock-based compensation |
(7,691 |
) |
|
(7,268 |
) |
|
(6,056 |
) |
||||
Performance based equity |
(6,642 |
) |
|
(8,249 |
) |
|
(6,190 |
) |
||||
Research and development funded by others |
— |
|
|
(3,800 |
) |
|
— |
|
||||
Acquisition and integration costs |
— |
|
|
(38 |
) |
|
— |
|
||||
Non-GAAP R&D expenses |
53,205 |
|
|
55,061 |
|
|
43,570 |
|
||||
|
|
|
|
|
|
|||||||
GAAP SG&A expenses |
38,469 |
|
|
35,885 |
|
|
41,685 |
|
||||
Stock-based compensation |
(8,179 |
) |
|
(6,551 |
) |
|
(7,349 |
) |
||||
Performance based equity |
(3,120 |
) |
|
(3,357 |
) |
|
(2,991 |
) |
||||
Amortization of purchased intangible assets |
(5,811 |
) |
|
(5,816 |
) |
|
(6,057 |
) |
||||
Acquisition and integration costs |
(135 |
) |
|
(25 |
) |
|
(7,762 |
) |
||||
IP litigation costs, net |
— |
|
|
— |
|
|
(35 |
) |
||||
Non-GAAP SG&A expenses |
21,224 |
|
|
20,136 |
|
|
17,491 |
|
||||
|
|
|
|
|
|
|||||||
GAAP restructuring expenses |
— |
|
|
38 |
|
|
3,280 |
|
||||
Restructuring charges |
— |
|
|
(38 |
) |
|
(3,280 |
) |
||||
Non-GAAP restructuring expenses |
— |
|
|
— |
|
|
— |
|
||||
|
|
|
|
|
|
|||||||
GAAP income (loss) from operations |
23,786 |
|
|
2,204 |
|
|
(34,575 |
) |
||||
Total non-GAAP adjustments |
42,595 |
|
|
46,160 |
|
|
64,389 |
|
||||
Non-GAAP income from operations |
66,381 |
|
|
48,364 |
|
|
29,814 |
|
||||
|
|
|
|
|
|
|||||||
GAAP loss on extinguishment of debt |
— |
|
|
(5,221 |
) |
|
— |
|
||||
Loss on extinguishment of debt |
— |
|
|
5,221 |
|
|
— |
|
||||
Non-GAAP loss on extinguishment of debt |
— |
|
|
— |
|
|
— |
|
||||
|
|
|
|
|
|
|||||||
GAAP and non-GAAP interest and other income (expense), net |
(2,726 |
) |
|
(4,260 |
) |
|
(4,261 |
) |
||||
Non-recurring interest and other income (expense), net |
73 |
|
|
133 |
|
|
— |
|
||||
Non-GAAP interest and other income (expense), net |
(2,653 |
) |
|
(4,127 |
) |
|
(4,261 |
) |
||||
|
|
|
|
|
|
|||||||
GAAP income (loss) before income taxes |
21,060 |
|
|
(7,277 |
) |
|
(38,836 |
) |
||||
Total non-GAAP adjustments |
42,668 |
|
|
51,514 |
|
|
64,389 |
|
||||
Non-GAAP income before income taxes |
63,728 |
|
|
44,237 |
|
|
25,553 |
|
||||
|
|
|
|
|
|
|||||||
GAAP income tax provision (benefit) |
11,802 |
|
|
(8,010 |
) |
|
(2,191 |
) |
||||
Adjustment for non-cash tax benefits/expenses |
(7,979 |
) |
|
10,665 |
|
|
3,724 |
|
||||
Non-GAAP income tax provision |
3,823 |
|
|
2,655 |
|
|
1,533 |
|
||||
|
|
|
|
|
|
|||||||
GAAP net income (loss) |
9,258 |
|
|
733 |
|
|
(36,645 |
) |
||||
Total non-GAAP adjustments before income taxes |
42,668 |
|
|
51,514 |
|
|
64,389 |
|
||||
Less: total tax adjustments |
(7,979 |
) |
|
10,665 |
|
|
3,724 |
|
||||
Non-GAAP net income |
$ |
59,905 |
|
|
$ |
41,582 |
|
|
$ |
24,020 |
|
|
|
|
|
|
|
|
|||||||
Shares used in computing non-GAAP basic net income per share |
76,582 |
|
|
75,930 |
|
|
73,402 |
|
||||
Shares used in computing non-GAAP diluted net income per share |
79,815 |
|
|
79,026 |
|
|
75,324 |
|
||||
Non-GAAP basic net income per share |
$ |
0.78 |
|
|
$ |
0.55 |
|
|
$ |
0.33 |
|
|
Non-GAAP diluted net income per share |
$ |
0.75 |
|
|
$ |
0.53 |
|
|
$ |
0.32 |
UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENTS (in thousands, except per share data) |
||||||||
|
Nine months ended |
|||||||
|
|
|
|
|||||
GAAP gross profit |
$ |
354,055 |
|
|
$ |
129,711 |
|
|
Stock-based compensation |
468 |
|
|
417 |
|
|||
Performance based equity |
332 |
|
|
358 |
|
|||
Amortization of inventory fair value adjustments |
— |
|
|
14,445 |
|
|||
Amortization of purchased intangible assets |
32,233 |
|
|
27,063 |
|
|||
Non-GAAP gross profit |
387,088 |
|
|
171,994 |
|
|||
|
|
|
|
|||||
GAAP R&D expenses |
205,120 |
|
|
109,489 |
|
|||
Stock-based compensation |
(22,121 |
) |
|
(14,842 |
) |
|||
Performance based equity |
(19,489 |
) |
|
(9,994 |
) |
|||
Research and development funded by others |
(3,800 |
) |
|
— |
|
|||
Acquisition and integration costs |
(130 |
) |
|
— |
|
|||
Non-GAAP R&D expenses |
159,580 |
|
|
84,653 |
|
|||
|
|
|
|
|||||
GAAP SG&A expenses |
110,823 |
|
|
93,787 |
|
|||
Stock-based compensation |
(20,354 |
) |
|
(17,202 |
) |
|||
Performance based equity |
(8,367 |
) |
|
(5,271 |
) |
|||
Amortization of purchased intangible assets |
(17,697 |
) |
|
(17,329 |
) |
|||
Acquisition and integration costs |
(1,721 |
) |
|
(13,122 |
) |
|||
IP litigation costs, net |
(11 |
) |
|
(149 |
) |
|||
Non-GAAP SG&A expenses |
62,673 |
|
|
40,714 |
|
|||
|
|
|
|
|||||
GAAP impairment losses |
— |
|
|
86 |
|
|||
Impairment losses |
— |
|
|
(86 |
) |
|||
Non-GAAP impairment losses |
— |
|
|
— |
|
|||
|
|
|
|
|||||
GAAP restructuring expenses |
2,204 |
|
|
3,833 |
|
|||
Restructuring charges |
(2,204 |
) |
|
(3,833 |
) |
|||
Non-GAAP restructuring expenses |
— |
|
|
— |
|
|||
|
|
|
|
|||||
GAAP income (loss) from operations |
35,908 |
|
|
(77,484 |
) |
|||
Total non-GAAP adjustments |
128,927 |
|
|
124,111 |
|
|||
Non-GAAP income from operations |
164,835 |
|
|
46,627 |
|
|||
|
|
|
|
|||||
GAAP loss on extinguishment of debt |
(5,221 |
) |
|
— |
|
|||
Loss on extinguishment of debt |
5,221 |
|
|
— |
|
|||
Non-GAAP loss on extinguishment of debt |
— |
|
|
— |
|
|||
|
|
|
|
|||||
GAAP and non-GAAP interest and other income (expense), net |
(11,296 |
) |
|
(8,565 |
) |
|||
Non-recurring interest and other income (expense), net |
516 |
|
|
— |
|
|||
Non-GAAP interest and other income (expense), net |
(10,780 |
) |
|
(8,565 |
) |
|||
|
|
|
|
|||||
GAAP income (loss) before income taxes |
19,391 |
|
|
(86,049 |
) |
|||
Total non-GAAP adjustments |
134,664 |
|
|
124,111 |
|
|||
Non-GAAP income before income taxes |
154,055 |
|
|
38,062 |
|
|||
|
|
|
|
|||||
GAAP income tax provision (benefit) |
5,598 |
|
|
(12,128 |
) |
|||
Adjustment for non-cash tax benefits/expenses |
3,645 |
|
|
14,412 |
|
|||
Non-GAAP income tax provision |
9,243 |
|
|
2,284 |
|
|||
|
|
|
|
|||||
GAAP net income (loss) |
13,793 |
|
|
(73,921 |
) |
|||
Total non-GAAP adjustments before income taxes |
134,664 |
|
|
124,111 |
|
|||
Less: total tax adjustments |
3,645 |
|
|
14,412 |
|
|||
Non-GAAP net income |
$ |
144,812 |
|
|
$ |
35,778 |
|
|
|
|
|
|
|||||
Shares used in computing non-GAAP basic net income per share |
75,795 |
|
|
72,729 |
|
|||
Shares used in computing non-GAAP diluted net income per share |
79,048 |
|
|
73,925 |
|
|||
Non-GAAP basic net income per share |
$ |
1.91 |
|
|
$ |
0.49 |
|
|
Non-GAAP diluted net income per share |
$ |
1.83 |
|
|
$ |
0.48 |
|
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES |
|||||||||
|
Three Months Ended |
||||||||
|
|
|
|
|
|
||||
GAAP gross profit |
56.5 |
% |
|
54.8 |
% |
|
42.3 |
% |
|
Stock-based compensation |
0.1 |
% |
|
0.1 |
% |
|
0.1 |
% |
|
Performance based equity |
0.1 |
% |
|
0.1 |
% |
|
0.1 |
% |
|
Amortization of inventory fair value adjustments |
— |
% |
|
— |
% |
|
9.2 |
% |
|
Amortization of purchased intangible assets |
4.7 |
% |
|
5.2 |
% |
|
6.3 |
% |
|
Non-GAAP gross profit |
61.3 |
% |
|
60.2 |
% |
|
58.0 |
% |
|
|
|
|
|
|
|
||||
GAAP R&D expenses |
29.4 |
% |
|
36.2 |
% |
|
35.6 |
% |
|
Stock-based compensation |
(3.4) |
% |
|
(3.5) |
% |
|
(3.9) |
% |
|
Performance based equity |
(2.9) |
% |
|
(4.0) |
% |
|
(4.0) |
% |
|
Research and development funded by others |
— |
% |
|
(1.9) |
% |
|
— |
% |
|
Acquisition and integration costs |
— |
% |
|
— |
% |
|
— |
% |
|
Non-GAAP R&D expenses |
23.2 |
% |
|
26.8 |
% |
|
27.8 |
% |
|
|
|
|
|
|
|
||||
GAAP SG&A expenses |
16.7 |
% |
|
17.5 |
% |
|
26.6 |
% |
|
Stock-based compensation |
(3.6) |
% |
|
(3.2) |
% |
|
(4.7) |
% |
|
Performance based equity |
(1.4) |
% |
|
(1.6) |
% |
|
(1.9) |
% |
|
Amortization of purchased intangible assets |
(2.5) |
% |
|
(2.8) |
% |
|
(3.9) |
% |
|
Acquisition and integration costs |
(0.1) |
% |
|
— |
% |
|
(5.0) |
% |
|
IP litigation costs, net |
— |
% |
|
— |
% |
|
— |
% |
|
Non-GAAP SG&A expenses |
9.2 |
% |
|
9.8 |
% |
|
11.2 |
% |
|
|
|
|
|
|
|
||||
GAAP impairment losses |
— |
% |
|
— |
% |
|
— |
% |
|
Impairment losses |
— |
% |
|
— |
% |
|
— |
% |
|
Non-GAAP impairment losses |
— |
% |
|
— |
% |
|
— |
% |
|
|
|
|
|
|
|
||||
GAAP restructuring expenses |
— |
% |
|
— |
% |
|
2.1 |
% |
|
Restructuring charges |
— |
% |
|
— |
% |
|
(2.1) |
% |
|
Non-GAAP restructuring expenses |
— |
% |
|
— |
% |
|
— |
% |
|
|
|
|
|
|
|
||||
GAAP income (loss) from operations |
10.4 |
% |
|
1.1 |
% |
|
(22.1) |
% |
|
Total non-GAAP adjustments |
18.5 |
% |
|
22.5 |
% |
|
41.1 |
% |
|
Non-GAAP income from operations |
28.9 |
% |
|
23.6 |
% |
|
19.0 |
% |
|
|
|
|
|
|
|
||||
GAAP loss on extinguishment of debt |
— |
% |
|
(2.5) |
% |
|
— |
% |
|
Loss on extinguishment of debt |
— |
% |
|
2.5 |
% |
|
— |
% |
|
Non-GAAP loss on extinguishment of debt |
— |
% |
|
— |
% |
|
— |
% |
|
|
|
|
|
|
|
||||
GAAP and non-GAAP interest and other income (expense), net |
(1.2) |
% |
|
(2.1) |
% |
|
(2.7) |
% |
|
Non-recurring interest and other income (expense), net |
— |
% |
|
0.1 |
% |
|
— |
% |
|
Non-GAAP interest and other income (expense), net |
(1.2) |
% |
|
(2.0) |
% |
|
(2.7) |
% |
|
|
|
|
|
|
|
||||
GAAP income (loss) before income taxes |
9.2 |
% |
|
(3.5) |
% |
|
(24.8) |
% |
|
Total non-GAAP adjustments before income taxes |
18.6 |
% |
|
25.1 |
% |
|
41.1 |
% |
|
Non-GAAP income before income taxes |
27.7 |
% |
|
21.5 |
% |
|
16.3 |
% |
|
|
|
|
|
|
|
||||
GAAP income tax provision (benefit) |
5.1 |
% |
|
(3.9) |
% |
|
(1.4) |
% |
|
Adjustment for non-cash tax benefits/expenses |
(3.5) |
% |
|
5.2 |
% |
|
2.4 |
% |
|
Non-GAAP income tax provision |
1.7 |
% |
|
1.3 |
% |
|
1.0 |
% |
|
|
|
|
|
|
|
||||
GAAP net income (loss) |
4.0 |
% |
|
0.4 |
% |
|
(23.4) |
% |
|
Total non-GAAP adjustments before income taxes |
18.6 |
% |
|
25.1 |
% |
|
41.1 |
% |
|
Less: total tax adjustments |
(3.5) |
% |
|
5.2 |
% |
|
2.4 |
% |
|
Non-GAAP net income |
26.1 |
% |
|
20.3 |
% |
|
15.3 |
% |
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES |
||||||
|
Nine months ended |
|||||
|
|
|
|
|||
GAAP gross profit |
54.9 |
% |
|
45.7 |
% |
|
Stock-based compensation |
0.1 |
% |
|
0.2 |
% |
|
Performance based equity |
0.1 |
% |
|
0.1 |
% |
|
Amortization of inventory fair value adjustments |
— |
% |
|
5.1 |
% |
|
Amortization of purchased intangible assets |
5.0 |
% |
|
9.5 |
% |
|
Non-GAAP gross profit |
60.1 |
% |
|
60.6 |
% |
|
|
|
|
|
|||
GAAP R&D expenses |
31.8 |
% |
|
38.6 |
% |
|
Stock-based compensation |
(3.4) |
% |
|
(5.2) |
% |
|
Performance based equity |
(3.0) |
% |
|
(3.5) |
% |
|
Research and development funded by others |
(0.6) |
% |
|
— |
% |
|
Acquisition and integration costs |
— |
% |
|
— |
% |
|
Non-GAAP R&D expenses |
24.8 |
% |
|
29.8 |
% |
|
|
|
|
|
|||
GAAP SG&A expenses |
17.2 |
% |
|
33.0 |
% |
|
Stock-based compensation |
(3.2) |
% |
|
(6.1) |
% |
|
Performance based equity |
(1.3) |
% |
|
(1.9) |
% |
|
Amortization of purchased intangible assets |
(2.8) |
% |
|
(6.1) |
% |
|
Acquisition and integration costs |
(0.3) |
% |
|
(4.6) |
% |
|
IP litigation costs, net |
— |
% |
|
(0.1) |
% |
|
Non-GAAP SG&A expenses |
9.7 |
% |
|
14.3 |
% |
|
|
|
|
|
|||
GAAP impairment losses |
— |
% |
|
0.03 |
% |
|
Impairment losses |
— |
% |
|
(0.03) |
% |
|
Non-GAAP impairment losses |
— |
% |
|
— |
% |
|
|
|
|
|
|||
GAAP restructuring expenses |
0.3 |
% |
|
1.4 |
% |
|
Restructuring charges |
(0.3) |
% |
|
(1.4) |
% |
|
Non-GAAP restructuring expenses |
— |
% |
|
— |
% |
|
|
|
|
|
|||
GAAP income (loss) from operations |
5.6 |
% |
|
(27.3) |
% |
|
Total non-GAAP adjustments |
20.0 |
% |
|
43.7 |
% |
|
Non-GAAP income from operations |
25.6 |
% |
|
16.4 |
% |
|
|
|
|
|
|||
GAAP loss on extinguishment of debt |
(0.8) |
% |
|
— |
% |
|
Loss on extinguishment of debt |
0.8 |
% |
|
— |
% |
|
Non-GAAP loss on extinguishment of debt |
— |
% |
|
— |
% |
|
|
|
|
|
|||
GAAP and non-GAAP interest and other income (expense), net |
(1.8) |
% |
|
(3.0) |
% |
|
Non-recurring interest and other income (expense), net |
0.1 |
% |
|
— |
% |
|
Non-GAAP interest and other income (expense), net |
(1.7) |
% |
|
(3.0) |
% |
|
|
|
|
|
|||
GAAP income (loss) before income taxes |
3.0 |
% |
|
(30.3) |
% |
|
Total non-GAAP adjustments |
20.9 |
% |
|
43.7 |
% |
|
Non-GAAP income before income taxes |
23.9 |
% |
|
13.4 |
% |
|
|
|
|
|
|||
GAAP income tax provision (benefit) |
0.9 |
% |
|
(4.3) |
% |
|
Adjustment for non-cash tax benefits/expenses |
0.6 |
% |
|
5.1 |
% |
|
Non-GAAP income tax provision |
1.4 |
% |
|
0.8 |
% |
|
|
|
|
|
|||
GAAP net income (loss) |
2.1 |
% |
|
(26.0) |
% |
|
Total non-GAAP adjustments before income taxes |
20.9 |
% |
|
43.7 |
% |
|
Less: total tax adjustments |
0.6 |
% |
|
5.1 |
% |
|
Non-GAAP net income |
22.5 |
% |
|
12.6 |
% |
View source version on businesswire.com: https://www.businesswire.com/news/home/20211027006029/en/
Tel: 949-333-0080
IR@maxlinear.com
Source:
FAQ
What were MaxLinear's Q3 2021 earnings results?
What is the guidance for MaxLinear's Q4 2021 revenue?
How did MaxLinear's gross margins perform in Q3 2021?
What were MaxLinear's operating expenses in Q3 2021?